Wednesday 8″ Dec” 2021″SOURCE: NEWS AGENCIES
Tijaabo shaybaar ayaa muujisay koorsada saddexda-shubane ee tallaalka Pfizer-BioNTech in uu ka takhalusayo Omicron, halka laba tallaal ay u muuqdaan kuwo waxtarkoodu yar yahay.new Omicron variant
Pfizer iyo lamaanaheeda BioNTech ayaa sheegaya in tijaabooyinka shaybaadhka ay muujiyeen qiyaasta xoojisay oo kordhay 25-laab heerka waxa loogu yeero unugyada difaaca jirka ee Omicron [
Pfizer waxay sheegtay in qiyaasta xoojisay ee tallaalkeeda COVID-19 ay awooday inay ka takhalusto kala duwanaanshaha Omicron-ka cusub ee daraasadaha shaybaadhka, inkasta oo labada qiyaas ee hore ay u muuqdaan kuwo waxtar yar u leh
Ku dhawaaqista Arbacada waa bayaankii ugu horreeyay ee rasmi ah oo ka soo baxa soo saarayaasha tallaalka ee ku saabsan waxtarka tallaalada hadda jira ee Omicron
Marka loo eego cilmi-baaristii hore ee shaybaarka iyadoo la adeegsanayo serumka dhiigga ee dadka la tallaalay, qiyaasta saddexaad ee xoojisa ayaa laga soo saaray isla heerka unugyada difaaca jirka ee Omicron sida lagu arko ka dib qiyaas labaad oo leh noocyo kale.
Saynis yahanadu waxay qiyaaseen in boodada sare ee unugyada difaaca jirka ee la socota qiyaasta saddexaad ee tallaalada COVID-19 ay ku filnaan karto inay ka hortagto hoos u dhac kasta oo ku yimaada waxtarka.
Heerarka antibody-ku waxay saadaaliyaan sida ugu wanaagsan ee tallaalku uga hortagi karo cudurka ‘coronavirus’ laakiin waa hal lakab oo ka mid ah difaaca habka difaaca jirka. Pfizer wuxuu sheegay in laba qiyaasood oo tallaalku ay wali keeni karaan ka-hortagga cudur daran.
“In kasta oo laba qiyaasood oo tallaalka ah laga yaabo inay weli bixiyaan ka-hortagga cudurrada daran ee uu keeno cadaadiska Omicron, waxaa iska cad xogtan hordhaca ah in ilaalinta lagu kordhiyo qiyaasta saddexaad ee tallaalkayaga,” maamulaha Pfizer Albert Bourla ayaa hadal uu soo saaray ku sheegay.
“In la hubiyo in inta ugu badan ee suurtogalka ah ay si buuxda u talaalaan labada qaybood ee ugu horreeya iyo xoojiye ayaa ah tallaabada ugu wanaagsan ee looga hortagayo fiditaanka COVID-19,” Bourla ayaa tir
Shirkaduhu waxay kaloo sheegeen in nooc gaar ah oo Omicron ah oo tallaalkooda coronavirus ah, kaas oo hadda la horumarinayo, la heli doono bisha Maarso.
Natiijooyinka ayaa si weyn ula socda daraasad horudhac ah oo ay daabaceen cilmi-baarayaal ka tirsan Machadka Cilmi-baarista Caafimaadka Afrika ee Koonfur Afrika Talaadadii, iyagoo sheegay in Omicron uu qayb ahaan ka baxsan karo ilaalinta laba qiyaasood oo tallaalka Pfizer-BioNTech ah. Natiijooyinka ayaa sidoo kale soo jeediyay in tallaalka saddexaad laga yaabo inuu kaa caawiyo iska ilaalinta caabuqa.
Omicron ayaa ilaa hadda laga helay 57 waddan, sida ay sheegtay Ururka Caafimaadka Adduunka, iyada oo in badan oo soo rogaal celiyay xannibaadaha safarka si loo joojiyo fiditaanka.
Wax dhimasho ah weli lama xiriirin kala duwanaanshahan, iyadoo saraakiisha caafimaadka qaarkood ay sheegeen in iyadoo Omicron laga yaabo inuu ka faafi karo noocyo hore, calaamadaha hore waxay muujinayaan inay sababi karto cudur ka yara daran.
XIGASHO: Wakaaladaha Wararka
